Publication | Open Access

LBA33 A first-in-human phase I study of a novel KRAS G12D inhibitor HRS-4642 in patients with advanced solid tumors harboring KRAS G12D mutation

Tumor BiologyKras G12d MutationFirst-in-human PhaseMedicinePathologyAdvanced Solid TumorsCancer GenomicsCancer BiologyCancer GeneticsOncologyCell BiologyCancer Research